InvestorsHub Logo

maumar

07/18/15 12:33 PM

#96 RE: harry crumb #94

I can't blame you for taking profits. I would think that some, possibly a lot, of the second drug approval upside is priced in now. I would be surprised if this goes to 200 in the next 6 months unless it gets acquired. I'm still holding but with some hesitation. Stock action is still strong, though